HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahsa M Amoli Selected Research

Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)

7/2002Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura.
5/2002Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahsa M Amoli Research Topics

Disease

12Obesity
11/2022 - 10/2007
9Type 2 Diabetes Mellitus (MODY)
03/2017 - 10/2007
7Neoplasms (Cancer)
12/2019 - 01/2012
7Purpura
06/2005 - 05/2002
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 11/2011
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2019 - 01/2006
4Carcinoma (Carcinomatosis)
01/2013 - 01/2009
4Erythema Nodosum
01/2011 - 08/2002
4Giant Cell Arteritis (Horton Disease)
01/2005 - 08/2003
3Breast Neoplasms (Breast Cancer)
12/2019 - 03/2017
3Inflammation (Inflammations)
12/2019 - 01/2014
3Papillary Thyroid Cancer
02/2012 - 01/2009
2Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 12/2019
2Endometriosis
12/2021 - 06/2019
2Alopecia Areata
10/2019 - 08/2019
2Diabetes Mellitus
09/2019 - 04/2012
2Vitiligo
08/2019 - 06/2019
2Sensorineural Hearing Loss
03/2019 - 01/2015
2Schizophrenia (Dementia Praecox)
01/2019 - 10/2011
2Abdominal Obesity
03/2017 - 09/2012
2Ulcer
01/2017 - 08/2011
2Diabetic Foot
01/2017 - 08/2011
2Meniere Disease (Menieres Disease)
09/2015 - 06/2011
2Body Weight (Weight, Body)
06/2015 - 10/2012
2Endometrial Neoplasms (Endometrial Cancer)
04/2015 - 01/2012
2Osteoporosis
01/2015 - 01/2014
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2012 - 01/2010
2Atherosclerosis
01/2012 - 11/2011
2Diabetic Neuropathies (Diabetic Neuropathy)
08/2011 - 10/2010
2Thyroid Neoplasms (Thyroid Cancer)
01/2010 - 01/2009
2Disease Susceptibility (Diathesis)
12/2004 - 08/2003
2Vascular Skin Diseases
02/2004 - 11/2002
2Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
08/2003 - 03/2002
2Nephritis
11/2002 - 05/2002
2Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
07/2002 - 05/2002
1Amyloidosis
04/2022
1Hypertension (High Blood Pressure)
01/2020
1Overweight
11/2019
1Morbid Obesity
08/2018
1Hypogonadism (Hypergonadotropic Hypogonadism)
08/2018
1Hyperphagia (Overeating)
08/2018
1Peripheral Nervous System Diseases (PNS Diseases)
02/2018
1Pemphigus (Pemphigus Vulgaris)
01/2018
1Bullous Pemphigoid (Pemphigoid)
01/2018
1Hyperglycemia
01/2017
1Hearing Loss (Hearing Impairment)
09/2015

Drug/Important Bio-Agent (IBA)

7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2019 - 09/2010
6CytokinesIBA
11/2019 - 01/2006
6AdiponectinIBA
03/2017 - 01/2010
5Messenger RNA (mRNA)IBA
12/2021 - 11/2011
4MicroRNAs (MicroRNA)IBA
11/2022 - 12/2019
4Proteins (Proteins, Gene)FDA Link
04/2022 - 06/2019
4Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2020 - 09/2003
4Macrophage Migration-Inhibitory FactorsIBA
10/2019 - 08/2002
4Calcitriol Receptors (Calcitriol Receptor)IBA
04/2019 - 01/2014
4SurvivinIBA
04/2015 - 01/2012
3Interleukin-6 (Interleukin 6)IBA
04/2022 - 01/2014
3Biomarkers (Surrogate Marker)IBA
12/2019 - 04/2017
3Apolipoproteins E (ApoE)IBA
03/2019 - 10/2012
3Chemokine CCL5IBA
09/2015 - 11/2002
3HLA-DRB1 Chains (HLA DRB1)IBA
01/2010 - 05/2002
2Adenosine DeaminaseIBA
06/2022 - 10/2007
2Amyloid (Amyloid Fibrils)IBA
04/2022 - 01/2014
2AntioxidantsIBA
09/2019 - 06/2015
2AcarboseFDA LinkGeneric
04/2017 - 06/2015
2Triglycerides (Triacylglycerol)IBA
06/2015 - 10/2012
2Blood Glucose (Blood Sugar)IBA
06/2015 - 10/2012
2LeptinIBA
06/2015 - 01/2015
2Inhibitor of Apoptosis ProteinsIBA
04/2015 - 01/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2014 - 09/2012
2CholesterolIBA
10/2012 - 10/2007
2HLA-C Antigens (HLA-C)IBA
06/2011 - 01/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2011 - 06/2005
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2011 - 02/2004
2Transcription Factors (Transcription Factor)IBA
07/2010 - 11/2009
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2010 - 07/2002
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2010 - 01/2009
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2004 - 03/2002
1Matrix Metalloproteinases (MMPs)IBA
04/2022
1SilymarinIBA
04/2022
1Insulin (Novolin)FDA Link
04/2022
1Transforming Growth Factor beta (TGF-beta)IBA
12/2021
1adducinIBA
01/2020
1Small Untranslated RNAIBA
12/2019
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
08/2019
1Transcription Factor 7-Like 2 ProteinIBA
08/2019
1Discoidin Domain Receptor 1IBA
06/2019
1Cadherins (E-Cadherin)IBA
06/2019
1Vitamin DFDA LinkGeneric
04/2019
1Competitive Endogenous RNAIBA
01/2019
1Leptin ReceptorsIBA
08/2018
1NAD (NADH)IBA
02/2018
1AutoantibodiesIBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1alpha-AmylasesIBA
04/2017
1EnzymesIBA
04/2017
1DNA (Deoxyribonucleic Acid)IBA
03/2017
1Free RadicalsIBA
01/2017

Therapy/Procedure

2Therapeutics
12/2019 - 08/2019
1Laparotomy
06/2019